New Triptan Drug, FROVA, available to treat Migraines

From CNW News Group in Canada:

    MONTREAL, Jan. 21 /CNW Telbec/ - Teva Neuroscience Canada announced today
the launch of FROVA(R) (frovatriptan succinate tablets), a unique treatment
for patients suffering from migraines. The single strength 2.5 mg tablets are
now available by prescription in pharmacies throughout Canada. This is
important news for those suffering from migraines who are not receiving
effective therapy at the current time.
    FROVA is indicated for the acute treatment of migraine attacks with or
without aura in adults. "The launch of FROVA in Canada is further proof of
Teva Neuroscience's commitment to patients suffering from neurology
disorders", announced Dr. Jean Godin, General Manager, Teva Neuroscience
Canada. "While there are other treatments currently available for patients
with migraines, our research shows that many patients are not satisfied with
the relief or tolerability offered by the current medications. FROVA has a
unique profile that may benefit many patients."

FROVA is a triptan, a common migraine-buster. Like others, FROVA should not be used for Basilar Migraines or Hemiplegic Migraines. Like most abortives, overuse will likely result in the dreaded rebound headache. Trust, you do not want to tread there. What sounds promising about FROVA is the half-life of 26 hours. That means the drug will stay in your system longer so one dose will carry you further (1/2 the drug will still be active after 26 hours, 1/2 of that 1/2, or 1/4 will still be active after the next 26 hours. So 2 days after you take the drug, 1/4 is still kicking migraine-ass). The FROVA web site, http://www.frova.com (in case you could not figure it out) also says the drug is good for Menstrual Migraines. I also know first hand the role my hormones (insulin, adrenalin) have been playing with my condition, I could only imagine the result of a monthly hormone jolt to the system.